LAL Clinical Reseach e Development Ltda Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2006
NCT01228656
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

LAL Clinica Pesquisa e Desenvolvimento Ltda